Indoco receives EU GMP certificate for its sterile manufacturing facility in Goa
News

Indoco receives EU GMP certificate for its sterile manufacturing facility in Goa

This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies

  • By IPP Bureau | July 26, 2025

Indoco Remedies Limited has received Certificate for EU Good Manufacturing Practices (GMP) Compliance from the European Health Authorities for its sterile drug product manufacturing facility, Goa Plant II located at L32, 33 and 34, Verna Industrial Estate, South Goa-403722.

The EU GMP certification issued by the European Health Authorities confirms that the site complies with the Good Manufacturing Practice requirements.

Commenting on the development, Aditi Panandikar, Managing Director, Indoco Remedies Ltd.said, “This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies. We remain fully committed to adhering to cGMP standards and consistently delivering quality products to customers and patients worldwide.”

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International